{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:13:05Z","timestamp":1790885585247,"version":"4.1.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1038\/ncpgasthep0521","type":"journal-article","created":{"date-parts":[[2006,6,2]],"date-time":"2006-06-02T06:18:41Z","timestamp":1149229121000},"page":"318-328","source":"Crossref","is-referenced-by-count":350,"title":["Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis"],"prefix":"10.1038","volume":"3","author":[{"given":"Ulrich","family":"Beuers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpgasthep0521_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00365529409103618","volume":"204","author":"AF Hofmann","year":"1994","unstructured":"Hofmann AF (1994) Pharmacology of ursodeoxycholic acid, an enterohepatic drug. Scand J Gastroenterol Suppl 204: 1\u201315","journal-title":"Scand J Gastroenterol Suppl"},{"key":"BFncpgasthep0521_CR2","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/BF01308413","volume":"30","author":"U Leuschner","year":"1985","unstructured":"Leuschner U et al. (1985) Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study. Dig Dis Sci 30: 642\u2013649","journal-title":"Dig Dis Sci"},{"key":"BFncpgasthep0521_CR3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S0140-6736(87)91610-2","volume":"1","author":"R Poupon","year":"1987","unstructured":"Poupon R et al. (1987) Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1: 834\u2013836","journal-title":"Lancet"},{"key":"BFncpgasthep0521_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1089-3261(03)00135-1","volume":"8","author":"G Paumgartner","year":"2004","unstructured":"Paumgartner G and Beuers U (2004) Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis 8: 67\u201381","journal-title":"Clin Liver Dis"},{"key":"BFncpgasthep0521_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0168-8278(01)00092-7","volume":"35","author":"KN Lazaridis","year":"2001","unstructured":"Lazaridis KN et al. (2001) Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. J Hepatol 35: 134\u2013146","journal-title":"J Hepatol"},{"key":"BFncpgasthep0521_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1053\/bega.2000.0107","volume":"14","author":"R Poupon","year":"2000","unstructured":"Poupon R and Poupon RE (2000) Treatment of primary biliary cirrhosis. Baillieres Best Pract Res Clin Gastroenterol 14: 615\u2013628","journal-title":"Baillieres Best Pract Res Clin Gastroenterol"},{"key":"BFncpgasthep0521_CR7","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","volume":"354","author":"J Goulis","year":"1999","unstructured":"Goulis J et al. (1999) Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet 354: 1053\u20131060","journal-title":"Lancet"},{"key":"BFncpgasthep0521_CR8","volume-title":"The Cochrane Database of Systematic Reviews","author":"C Gluud","year":"2002","unstructured":"Gluud C and Christensen E (2002) Ursodeoxycholic acid for primary biliary cirrhosis. The Cochrane Database of Systematic Reviews, Issue 4, Art. No CD000551"},{"key":"BFncpgasthep0521_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0168-8278(00)80232-9","volume":"32","author":"RE Poupon","year":"2000","unstructured":"Poupon RE (2000) Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past\u2014issues for the future. J Hepatol 32: 685\u2013688","journal-title":"J Hepatol"},{"key":"BFncpgasthep0521_CR10","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/S0168-8278(97)80146-8","volume":"27","author":"J Palma","year":"1997","unstructured":"Palma J et al. (1997) Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol 27: 1022\u20131028","journal-title":"J Hepatol"},{"key":"BFncpgasthep0521_CR11","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/hep.20952","volume":"42","author":"A Glantz","year":"2005","unstructured":"Glantz A et al. (2005) Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 42: 1399\u20131405","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR12","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1053\/j.gastro.2005.06.019","volume":"129","author":"J Kondrackiene","year":"2005","unstructured":"Kondrackiene J et al. (2005) Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 129: 894\u2013901","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1152\/physrev.00027.2002","volume":"83","author":"M Trauner","year":"2003","unstructured":"Trauner M and Boyer JL (2003) Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83: 633\u2013671","journal-title":"Physiol Rev"},{"key":"BFncpgasthep0521_CR14","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1023\/A:1026686530785","volume":"44","author":"P Sauer","year":"1999","unstructured":"Sauer P et al. (1999) Influence of cholestasis on absorption of ursodeoxycholic acid. Dig Dis Sci 44: 817\u2013822","journal-title":"Dig Dis Sci"},{"key":"BFncpgasthep0521_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/gut.2005.067389","volume":"55","author":"P Hruz","year":"2006","unstructured":"Hruz P et al. (2006) Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis. Gut 55: 395\u2013402","journal-title":"Gut"},{"key":"BFncpgasthep0521_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0016-5085(94)94899-2","volume":"106","author":"RP Jazrawi","year":"1994","unstructured":"Jazrawi RP et al. (1994) Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology 106: 134\u2013142","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/hep.510250104","volume":"25","author":"JF Medina","year":"1997","unstructured":"Medina JF et al. (1997) Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology 25: 12\u201317","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1053\/gast.2001.25542","volume":"121","author":"P Fickert","year":"2001","unstructured":"Fickert P et al. (2001) Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 121: 170\u2013183","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR19","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","volume":"129","author":"HU Marschall","year":"2005","unstructured":"Marschall HU et al. (2005) Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 129: 476\u2013485","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR20","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1053\/jhep.2001.24034","volume":"33","author":"U Beuers","year":"2001","unstructured":"Beuers U et al. (2001) Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology 33: 1206\u20131216","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1053\/gast.2001.26262","volume":"121","author":"AK Kurz","year":"2001","unstructured":"Kurz AK et al. (2001) Tauroursodesoxycholate-induced choleresis involves p38 (MAPK) activation and translocation of the bile salt export pump in rats. Gastroenterology 121: 407\u2013419","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/labinvest.3700371","volume":"86","author":"F Dombrowski","year":"2006","unstructured":"Dombrowski F et al. (2006) Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver. Lab Invest 86: 166\u2013174","journal-title":"Lab Invest"},{"key":"BFncpgasthep0521_CR23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1053\/j.gastro.2003.11.003","volume":"126","author":"R Kubitz","year":"2004","unstructured":"Kubitz R et al. (2004) Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP kinase. Gastroenterology 126: 541\u2013553","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1055\/s-2007-1007230","volume":"16","author":"JM Crawford","year":"1996","unstructured":"Crawford JM (1996) Role of vesicle-mediated transport pathways in hepatocellular bile secretion. Semin Liver Dis 16: 169\u2013189","journal-title":"Semin Liver Dis"},{"key":"BFncpgasthep0521_CR25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/S0076-6879(05)00030-3","volume":"400","author":"R Kubitz","year":"2005","unstructured":"Kubitz R et al. (2005) Biliary transport systems: short-term regulation. Methods Enzymol 400: 542\u2013557","journal-title":"Methods Enzymol"},{"key":"BFncpgasthep0521_CR26","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1172\/JCI116921","volume":"92","author":"U Beuers","year":"1993","unstructured":"Beuers U et al. (1993) Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca2+ mechanisms defective in cholestasis. J Clin Invest 92: 2984\u20132993","journal-title":"J Clin Invest"},{"key":"BFncpgasthep0521_CR27","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/0016-5085(93)90433-D","volume":"104","author":"U Beuers","year":"1993","unstructured":"Beuers U et al. (1993) Effects of tauroursodeoxycholic acid on cytosolic Ca2+ signals in isolated rat hepatocytes. Gastroenterology 104: 604\u2013612","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR28","first-page":"G243","volume":"264","author":"B Bouscarel","year":"1993","unstructured":"Bouscarel B et al. (1993) Ursodeoxycholate mobilizes intracellular Ca2+ and activates phosphorylase a in isolated hepatocytes. Am J Physiol 264 (Pt 1): G243\u2013G251","journal-title":"Am J Physiol"},{"key":"BFncpgasthep0521_CR29","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1053\/gast.1996.v110.pm8613063","volume":"110","author":"U Beuers","year":"1996","unstructured":"Beuers U et al. (1996) Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology 110: 1553\u20131563","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR30","first-page":"G293","volume":"271","author":"RT Stravitz","year":"1996","unstructured":"Stravitz RT et al. (1996) Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7 alpha-hydroxylase. Am J Physiol 271 (Pt 1): G293\u2013G303","journal-title":"Am J Physiol"},{"key":"BFncpgasthep0521_CR31","first-page":"G300","volume":"268","author":"B Bouscarel","year":"1995","unstructured":"Bouscarel B et al. (1995) Ursodeoxycholic acid inhibits glucagon-induced cAMP formation in hamster hepatocytes: a role for PKC. Am J Physiol 268 (Pt 1): G300\u2013G310","journal-title":"Am J Physiol"},{"key":"BFncpgasthep0521_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1053\/gast.1999.0029900433","volume":"117","author":"B Bouscarel","year":"1999","unstructured":"Bouscarel B et al. (1999) Signal transduction and hepatocellular bile acid transport: cross talk between bile acids and second messengers. Gastroenterology 117: 433\u2013452","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/gut.51.1.113","volume":"51","author":"P Milkiewicz","year":"2002","unstructured":"Milkiewicz P et al. (2002) Hepatoprotection with tauroursodeoxycholate and beta muricholate against taurolithocholate induced cholestasis: involvement of signal transduction pathways. Gut 51: 113\u2013119","journal-title":"Gut"},{"key":"BFncpgasthep0521_CR34","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/hep.510280601","volume":"28","author":"U Beuers","year":"1998","unstructured":"Beuers U et al. (1998) Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications. Hepatology 28: 1449\u20131453","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR35","doi-asserted-by":"publisher","first-page":"10323","DOI":"10.1074\/jbc.M306242200","volume":"279","author":"R Kubitz","year":"2004","unstructured":"Kubitz R et al. (2004) Ca2+-dependent protein kinase C isoforms induce cholestasis in rat liver. J Biol Chem 279: 10323\u201310330","journal-title":"J Biol Chem"},{"key":"BFncpgasthep0521_CR36","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/hep.510290227","volume":"29","author":"U Beuers","year":"1999","unstructured":"Beuers U et al. (1999) Modulation of protein kinase C by taurolithocholic acid in isolated rat hepatocytes. Hepatology 29: 477\u2013482","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR37","doi-asserted-by":"publisher","first-page":"17810","DOI":"10.1074\/jbc.M209898200","volume":"278","author":"U Beuers","year":"2003","unstructured":"Beuers U et al. (2003) Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets. J Biol Chem 278: 17810\u201317818","journal-title":"J Biol Chem"},{"key":"BFncpgasthep0521_CR38","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/S0016-5085(03)00274-9","volume":"124","author":"D Haussinger","year":"2003","unstructured":"Haussinger D et al. (2003) Involvement of integrins and Src in tauroursodeoxycholate-induced and swelling-induced choleresis. Gastroenterology 124: 1476\u20131487","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR39","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1053\/gast.1997.v113.pm9322526","volume":"113","author":"F Schliess","year":"1997","unstructured":"Schliess F et al. (1997) Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver. Gastroenterology 113: 1306\u20131314","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR40","first-page":"283","volume":"23","author":"A Stiehl","year":"1995","unstructured":"Stiehl A et al. (1995) Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment. J Hepatol 23: 283\u2013289","journal-title":"J Hepatol"},{"key":"BFncpgasthep0521_CR41","unstructured":"Boyer JL et al. Up-regulation of a basolateral FXR-dependent bile acid efflux transporter, OST\u03b1\u2013OST\u03b2, in cholestasis in humans and rodents. Am J Physiol Gastrointest Liver Physiol, in press"},{"key":"BFncpgasthep0521_CR42","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1053\/jhep.2001.24171","volume":"33","author":"J Noe","year":"2001","unstructured":"Noe J et al. (2001) Characterization of the mouse bile salt export pump overexpressed in the baculovirus system. Hepatology 33: 1223\u20131231","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1172\/JCI4765","volume":"103","author":"W Faubion","year":"1999","unstructured":"Faubion W et al. (1999) Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 103: 137\u2013145","journal-title":"J Clin Invest"},{"key":"BFncpgasthep0521_CR44","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0016-5085(03)01055-2","volume":"125","author":"R Reinehr","year":"2003","unstructured":"Reinehr R et al. (2003) Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. Gastroenterology 125: 839\u2013853","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0168-8278(98)80208-0","volume":"28","author":"C Benz","year":"1998","unstructured":"Benz C et al. (1998) Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. J Hepatol 28: 99\u2013106","journal-title":"J Hepatol"},{"key":"BFncpgasthep0521_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF03401914","volume":"4","author":"C Rodrigues","year":"1998","unstructured":"Rodrigues C et al. (1998) Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 4: 165\u2013178","journal-title":"Mol Med"},{"key":"BFncpgasthep0521_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.1365-2362.2000.00615.x","volume":"30","author":"C Benz","year":"2000","unstructured":"Benz C et al. (2000) Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes. Eur J Clin Invest 30: 203\u2013209","journal-title":"Eur J Clin Invest"},{"key":"BFncpgasthep0521_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/jhep.2002.34511","volume":"36","author":"F Azzaroli","year":"2002","unstructured":"Azzaroli F et al. (2002) Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes. Hepatology 36: 49\u201354","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR49","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1053\/gast.2002.32976","volume":"122","author":"D Graf","year":"2002","unstructured":"Graf D et al. (2002) Taurolithocholic acid-3 sulfate induces CD95 trafficking and apoptosis in a c-Jun N-terminal kinase-dependent manner. Gastroenterology 122: 1411\u20131427","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR50","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/hep.20246","volume":"39","author":"MH Schoemaker","year":"2004","unstructured":"Schoemaker MH et al. (2004) Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39: 1563\u20131573","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR51","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/hep.20870","volume":"42","author":"S Sola","year":"2005","unstructured":"Sola S et al. (2005) Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-\u03b21-induced apoptosis in rat hepatocytes. Hepatology 42: 925\u2013934","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR52","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jhep.2004.10.016","volume":"42","author":"P Fickert","year":"2005","unstructured":"Fickert P et al. (2005) Oncosis represents the main type of cell death in mouse models of cholestasis. J Hepatol 42: 378\u2013385","journal-title":"J Hepatol"},{"key":"BFncpgasthep0521_CR53","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jhep.2004.12.014","volume":"42","author":"ME Guicciardi","year":"2005","unstructured":"Guicciardi ME and Gores GJ (2005) Cholestatic hepatocellular injury: what do we know and how should we proceed? J Hepatol 42: 297\u2013300","journal-title":"J Hepatol"},{"key":"BFncpgasthep0521_CR54","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/hep.510300332","volume":"30","author":"M Paolini","year":"1999","unstructured":"Paolini M et al. (1999) Bile acid structure and selective modulation of murine hepatic cytochrome P450-linked enzymes. Hepatology 30: 730\u2013739","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR55","doi-asserted-by":"publisher","first-page":"39411","DOI":"10.1074\/jbc.M106340200","volume":"276","author":"EG Schuetz","year":"2001","unstructured":"Schuetz EG et al. (2001) Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem 276: 39411\u201339418","journal-title":"J Biol Chem"},{"key":"BFncpgasthep0521_CR56","doi-asserted-by":"publisher","first-page":"38685","DOI":"10.1074\/jbc.M105127200","volume":"276","author":"K Bodin","year":"2001","unstructured":"Bodin K et al. (2001) Antiepileptic drugs increase plasma levels of 4\u03b2-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. J Biol Chem 276: 38685\u201338689","journal-title":"J Biol Chem"},{"key":"BFncpgasthep0521_CR57","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/hep.20568","volume":"41","author":"K Dilger","year":"2005","unstructured":"Dilger K et al. (2005) No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis. Hepatology 41: 595\u2013602","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/hep.1840110104","volume":"11","author":"Y Calmus","year":"1990","unstructured":"Calmus Y et al. (1990) Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 11: 12\u201315","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR59","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.4049\/jimmunol.156.4.1601","volume":"156","author":"H Tanaka","year":"1996","unstructured":"Tanaka H et al. (1996) Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway. J Immunol 156: 1601\u20131608","journal-title":"J Immunol"},{"key":"BFncpgasthep0521_CR60","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/00042737-200502000-00007","volume":"17","author":"C Weitzel","year":"2005","unstructured":"Weitzel C et al. (2005) Ursodeoxycholic acid induced activation of the glucocorticoid receptor in primary rat hepatocytes. Eur J Gastroenterol Hepatol 17: 169\u2013177","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BFncpgasthep0521_CR61","first-page":"24","volume":"14","author":"AF Hofmann","year":"1999","unstructured":"Hofmann AF (1999) Bile acids: the good, the bad, and the ugly. News Physiol Sci 14: 24\u201329","journal-title":"News Physiol Sci"},{"key":"BFncpgasthep0521_CR62","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","volume":"127","author":"P Fickert","year":"2004","unstructured":"Fickert P et al. (2004) Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 127: 261\u2013274","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR63","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0022-2275(20)37599-4","volume":"37","author":"DM Heuman","year":"1996","unstructured":"Heuman DM et al. (1996) Adsorption of mixtures of bile salt taurine conjugates to lecithin-cholesterol membranes: implications for bile salt toxicity and cytoprotection. J Lipid Res 37: 562\u2013573","journal-title":"J Lipid Res"},{"key":"BFncpgasthep0521_CR64","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/j.1572-0241.1998.00470.x","volume":"93","author":"KD Lindor","year":"1998","unstructured":"Lindor KD et al. (1998) Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis. Am J Gastroenterol 93: 1498\u20131504","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0521_CR65","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/hep.20370","volume":"40","author":"D Rost","year":"2004","unstructured":"Rost D et al. (2004) Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis. Hepatology 40: 693\u2013698","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR66","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/gast.1996.v111.pm8698195","volume":"111","author":"CM Van Nieuwkerk","year":"1996","unstructured":"Van Nieuwkerk CM et al. (1996) Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology 111: 165\u2013171","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR67","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1053\/gast.2002.35948","volume":"123","author":"P Fickert","year":"2002","unstructured":"Fickert P et al. (2002) Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 123: 1238\u20131251","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR68","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1053\/jhep.2002.32712","volume":"35","author":"G Alpini","year":"2002","unstructured":"Alpini G et al. (2002) Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha. Hepatology 35: 1041\u20131052","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3580001","volume":"358","author":"MH Nathanson","year":"2001","unstructured":"Nathanson MH et al. (2001) Stimulation of ATP secretion in the liver by therapeutic bile acids. Biochem J 358: 1\u20135","journal-title":"Biochem J"},{"key":"BFncpgasthep0521_CR70","doi-asserted-by":"publisher","first-page":"G1059","DOI":"10.1152\/ajpgi.2001.281.4.G1059","volume":"281","author":"JA Dranoff","year":"2001","unstructured":"Dranoff JA et al. (2001) Polarized expression and function of P2Y ATP receptors in rat bile duct epithelia. Am J Physiol Gastrointest Liver Physiol 281: G1059\u2013G1067","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFncpgasthep0521_CR71","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0016-5085(99)70564-0","volume":"117","author":"J Prieto","year":"1999","unstructured":"Prieto J et al. (1999) Assessment of biliary bicarbonate secretion in humans by positron emission tomography. Gastroenterology 117: 167\u2013172","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR72","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/hep.1840120521","volume":"12","author":"P Marteau","year":"1990","unstructured":"Marteau P et al. (1990) Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man. Hepatology 12: 1206\u20131208","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR73","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1136\/gut.32.9.1044","volume":"32","author":"S Eusufzai","year":"1991","unstructured":"Eusufzai S et al. (1991) Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test. Gut 32: 1044\u20131048","journal-title":"Gut"},{"key":"BFncpgasthep0521_CR74","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/0016-5085(90)90834-N","volume":"98","author":"A Stiehl","year":"1990","unstructured":"Stiehl A et al. (1990) Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids. Gastroenterology 98: 424\u2013428","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR75","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1136\/gut.52.9.1371","volume":"52","author":"A Lanzini","year":"2003","unstructured":"Lanzini A et al. (2003) Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration. Gut 52: 1371\u20131375","journal-title":"Gut"},{"key":"BFncpgasthep0521_CR76","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1136\/gut.52.9.1239","volume":"52","author":"AF Hofmann","year":"2003","unstructured":"Hofmann AF (2003) Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry. Gut 52: 1239\u20131241","journal-title":"Gut"},{"key":"BFncpgasthep0521_CR77","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/hep.1840150409","volume":"15","author":"U Beuers","year":"1992","unstructured":"Beuers U et al. (1992) Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease. Hepatology 15: 603\u2013608","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR78","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/hep.1840170614","volume":"17","author":"G Rudolph","year":"1993","unstructured":"Rudolph G et al. (1993) Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis. Hepatology 17: 1028\u20131032","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR79","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.1840160213","volume":"16","author":"M Yoshikawa","year":"1992","unstructured":"Yoshikawa M et al. (1992). Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology 16: 358\u2013364","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR80","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/hep.1840160317","volume":"16","author":"Y Calmus","year":"1992","unstructured":"Calmus Y et al. (1992) Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-alpha production by monocytes. Hepatology 16: 719\u2013723","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR81","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/hep.510250423","volume":"25","author":"A Bergamini","year":"1997","unstructured":"Bergamini A et al. (1997) Bile acids with differing hydrophilic\u2013hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cells. Hepatology 25: 927\u2013933","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR82","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/0016-5085(92)91739-Q","volume":"102","author":"JL Poo","year":"1992","unstructured":"Poo JL et al. (1992) Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat. Gastroenterology 102: 1752\u20131759","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0521_CR83","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1053\/jhep.2000.20240","volume":"32","author":"C Corpechot","year":"2000","unstructured":"Corpechot C et al. (2000) The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Hepatology 32: 1196\u20131199","journal-title":"Hepatology"},{"key":"BFncpgasthep0521_CR84","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0168-8278(91)90870-H","volume":"13","author":"U Beuers","year":"1991","unstructured":"Beuers U et al. (1991) Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man. J Hepatol 13: 97\u2013103","journal-title":"J Hepatol"},{"key":"BFncpgasthep0521_CR85","doi-asserted-by":"publisher","first-page":"20210","DOI":"10.1074\/jbc.M909992199","volume":"275","author":"C Rust","year":"2000","unstructured":"Rust C et al. (2000) The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3- kinase-dependent survival signaling cascade. J Biol Chem 275: 20210\u201320216","journal-title":"J Biol Chem"}],"container-title":["Nature Clinical Practice Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0521","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:03:12Z","timestamp":1684425792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpgasthep0521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["BFncpgasthep0521"],"URL":"https:\/\/doi.org\/10.1038\/ncpgasthep0521","relation":{},"ISSN":["1743-4378","1743-4386"],"issn-type":[{"value":"1743-4378","type":"print"},{"value":"1743-4386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}